Weight Loss

What to Look for in a Protein Powder?

Besides a balanced diet, many individuals opt to include supplements as part of their daily food intake. Protein powder is one such supplement which has become increasingly popular over recent years, with many users who want to achieve weight loss and muscle growth.

Weight Loss After Bariatric Surgery

Cachexia / Wasting Syndrome

GLP-1 and Diet: Evidence-Based Strategies for Better Weight Loss

How Does Semaglutide Work to Lose Weight?

Oral GLP-1 Pills for Weight Loss: How Orforglipron Works

Semaglutide and Weight Loss in Menopause

How Oral GLP-1 Drugs Work For Weight Loss

Does Cinnamon Help with Weight Loss?

What Is Cancer Cachexia? Causes, Symptoms, Diagnosis, and Treatment

Who Should Take Weight Loss Injections, and Who Shouldn’t?

Mental Health Disorders, Weight Gain, and Exercise

See more featured articles »

Is Cottage Cheese Good for Weight Loss? Evidence from Clinical Studies

Unexplained Weight Loss: When It Might Signal a Health Problem

The Natural Molecule That Could Rival Ozempic

Wegovy: A Breakthrough in Weight Loss?

Circadian Rhythm and Weight Loss

Military Diet: Health Risks

Cachexia and Cancer

Vegetarian Diets for Weight Loss

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Is a Hypocaloric Diet Safe and Effective for Long-Term Health?

Latest Weight Loss News and Research

AI tool predicts optimal feeding tube timing for people with MND

A new AI tool that accurately predicts the need for a feeding tube could transform patient care and improve quality of life for people living with Motor Neurone Disease (MND).

13 Feb 2026

Parkinson's-related weight loss reflects a failure of the body's energy-producing pathways

Weight loss is a well-recognized but poorly understood non-motor feature of Parkinson's disease (PD). Many patients progressively lose weight as the disease advances, often alongside worsening motor symptoms and quality of life.

13 Feb 2026

Ozempic users continue treatment when weight loss works despite side effects

A study on Ozempic for weight loss reveals user satisfaction is driven by efficacy, despite common gastrointestinal side effects impacting treatment adherence.

13 Feb 2026

Weight loss drug tirzepatide may lower the risk of diabetic retinopathy

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators.

11 Feb 2026

Semaglutide lowers cardiovascular events even without major weight loss, researchers report

Semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease regardless of baseline adiposity. Cardiovascular benefit was largely independent of overall weight loss, with waist circumference reduction explaining only part of the effect.

11 Feb 2026

Northwestern scientists develop advanced organoid model for human spinal cord injury

Northwestern University scientists have developed the most advanced organoid model for human spinal cord injury to date.

11 Feb 2026

High-fat diets cause more damage to metabolic health than carbohydrates

In recent years, many media reports and social media influencers have emphasized the dangers of eating too many carbohydrates.

10 Feb 2026

Obesity drives one in ten infectious disease deaths

Just over one in 10 deaths from a wide range of infectious diseases can be attributed to obesity worldwide, finds a major new study led by a University College London (UCL) researcher.

9 Feb 2026

Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation

Tirzepatide significantly improved cardiometabolic risk markers in adults with obesity and moderate to severe obstructive sleep apnea in the SURMOUNT-OSA phase 3 trials. Mediation analyses suggest both weight loss and reduced sleep-disordered breathing contributed to improvements in inflammation, insulin resistance, lipids, and blood pressure.

9 Feb 2026

Time-restricted feeding reduces disease activity and inflammation in Crohn's patients

A new randomized controlled study funded by the Crohn's & Colitis Foundation found that time-restricted feeding-a form of intermittent fasting-significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn's disease and overweight or obesity.

9 Feb 2026

Carotid artery procedures do not improve cognitive performance

Improving blood flow to the brain by opening a narrowed neck artery may not improve patients' cognitive skills, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.

4 Feb 2026

Color vision deficiency is linked to worse survival in bladder cancer

The study highlights how color vision deficiency can delay bladder cancer diagnosis, increasing mortality risk and underscoring the need for targeted screening.

28 Jan 2026

Study explores link between sex hormones and heart disease risk in type 2 diabetes

People with type 2 diabetes face a higher risk of heart attacks, strokes and other cardiovascular problems, according to the National Institutes of Health.

27 Jan 2026

Midlife insulin levels influence timing and duration of menopausal vasomotor symptoms

A woman's insulin levels in midlife are linked to the timing and duration of menopausal hot flashes, night sweats and cold sweats, according to new research from the University of Victoria (UVic).

27 Jan 2026

Why exercise is essential for restoring fitness after GLP-1-based weight loss

This randomized controlled trial shows that structured moderate-to-vigorous exercise, alone or combined with liraglutide, improves physical function and cardiorespiratory fitness after diet-induced weight loss in adults with obesity. In contrast, liraglutide alone sustains weight loss but does not significantly improve measured physical fitness outcomes.

26 Jan 2026

Menopausal hormone therapy linked to greater weight loss with tirzepatide

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight and obesity.

22 Jan 2026

When you eat matters: early time-restricted eating improves metabolic health

Time-restricted eating improves several metabolic outcomes compared with usual diets, with benefits observed for body weight, adiposity, blood pressure, insulin, glucose, and triglycerides. Early eating windows consistently outperform late eating, while the optimal duration of food intake remains uncertain.

22 Jan 2026

NuSHs can be a promising therapeutic strategy for preventing MASH-related hepatocellular carcinoma

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), represent the most common chronic liver diseases in Western populations, driven largely by obesity and insulin resistance.

21 Jan 2026

Plasma protein profiling can help detect cancer in patients with non-specific symptoms

A simple blood test can help detect cancer in patients with non-specific symptoms such as fatigue, pain or weight loss. This is according to a Swedish study from Karolinska Institutet, Danderyd Hospital and others, published in Nature Communications.

19 Jan 2026

UK patients seeking surgery overseas are returning with complications the NHS must treat

Outward medical tourism for surgery results in serious complications, creating challenges for the NHS and highlighting the need for better patient awareness.

16 Jan 2026